Lapad, Gina G.
HRN: 22-77-06 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/22/2023
CEFUROXIME 500MG (TAB)
03/22/2023
03/29/2023
PO
1 Tab
BID
NSVD With RMLE An Repair
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes